Investing Profile

Dylan Morris

VCInvestor
Managing Director at Insight Partners
insightpartners.com/team/dyla...San Francisco Bay Area
Photo of Dylan Morris, Managing Director at Insight Partners
Your Intro Paths to Dylan Morris

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Dylan is a member of
Harvard University Network
402 CONNECTIONS
Insight Partners Network
89 CONNECTIONS
CRV Network
29 CONNECTIONS
Charles River Ventures Network
24 CONNECTIONS
Innovation Endeavors Network
23 CONNECTIONS

Find Dylan Morris on

cb
Current Investing Position
Insight Partners Managing Director
Investment Range
$10.0M - $350.0M
Sweet Spot
$25.0M
Investments On Record
19
Current Fund Size
$20B

Dylan Morris is on these Sector & Stage Rankings

Dylan Morris's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
ImmuneBridge
SeedMar 2026$8M
SeedJan 2023$12M
$20M
Co-investors: Semyon Dukach (One Way Ventures)
Profluent Bio
Series BNov 2025$110M
Series UnknownMar 2024$35M
SeedAug 2022$9M
$150M
Co-investors: Nabeel Hyatt (Spark Capital)
Gameto
Series CAug 2025$44M
Series BMay 2024$33M
Series UnknownSep 2022$17M
$120M
Co-investors: Dan Rose (Coatue), Jack Abraham (Atomico), Maryanna Saenko (Baruch Future Ventures), Steve Jurvetson (Baruch Future Ventures), Anne Wojcicki (23andMe), Dusan Perovic (Two Sigma Ventures), Robert Nelsen (ARCH Venture Partners), Peter Kolchinsky (RA Capital), Kristina Simmons (Overwater Ventures), Viktoriya Tigipko (TA Ventures)
ArrePath
SeedJun 2025
SeedMar 2022$20M
$20M
Co-investors: Fei Shen (Boehringer Ingelheim Venture Fund), Venkat Srinivasan (Innospark Ventures)
PhaseV
Series AMay 2025$50M
$65M
Co-investors: Aniq Kassam (Stealth Capital), Zvika Orron (Viola Ventures)
Superluminal Medicines
Series ASep 2024$120M
$150M
Co-investors: Andrew Levin (RA Capital)
Unlearn.AI
Series CFeb 2024$50M
Series BApr 2022$50M
$120M
Co-investors: Francisco Gimenez (8VC), Rob Toews (Radical Ventures), Jack Boren
Capacity Bio
Series AMar 2023$35M
$35M
Co-investors: Taro Inaba (Remiges Ventures)

Dylan Morris's Experience

Board Director Exsilio Therapeutics2024 - Present
Board Director Superluminal Medicines Inc.2023 - Present
Board Director ImmuneBridge2023 - Present
Board Director Profluent Bio2022 - Present
Board Director Unlearn.AI2022 - Present
Board Director Capacity Bio2022 - Present
Board Director DEM Biopharma, Inc.2022 - Present
Managing Director Insight Partners2021 - Present
Board Director ArrePath2021 - Present
Board Director Switch Therapeutics2020 - Present
Board Director Deciduous Therapeutics2019 - Present
Board Observer Exo Therapeutics2019 - Present
Board Director Dyno Therapeutics2018 - Present
Board Observer Plexium2018 - Present
Board Director Unlearn.aiPresent
General Partner Charles River VenturesPresent
Board Director Averna TherapeuticsPresent
Board Director ProfluentPresent
Board Director Gameto2022 - 2024
Board Observer NanoMosaic Inc.2021 - 2023
General Partner CRV2017 - 2021
Investment Team Innovation Endeavors2015 - 2017
Co-Founder Integrated Plasmonics Corporation2011 - 2014

Dylan Morris's Education

Harvard University AB Computer Science
Caltech Graduate Research Biochemistry and Molecular Biophysics